By Wenhao Zhu·Updated 2026-10-16·12 min read
Key facts
- A PET-CT fuses a metabolic PET map with a detailed CT image. A hot spot is not automatically cancer, and a clean scan does not automatically rule it out.
- Current guidance strongly recommends PET-CT for solid pulmonary nodules with a solid component larger than 8 mm and for lymphoma; other uses are selective and depend on the clinical question.
- Whole-body PET-CT is not recommended as a cancer screen for people without symptoms or risk factors (ACR, SNMMI, and Beijing’s municipal health authority).
- Preparation decides image quality: fast for four to six hours, keep blood glucose controlled, avoid strenuous activity for about 24 hours, and stay warm.
- A whole-body FDG study typically delivers roughly 8–24 mSv of effective dose; do not repeat one within about three months without a specific clinical reason.
A PET-CT is among the most sensitive whole-body imaging tests in routine clinical use — and one of the most widely misunderstood. It does not simply photograph the body. It maps how actively cells are consuming glucose, and lays that map over a detailed CT image of your anatomy. A bright spot is not automatically cancer, and a clean scan does not automatically rule it out.
That gap between what patients expect and what the scan can actually deliver is where most of the trouble lies: scans done for no clinical reason, weeks of anxiety after a finding that turns out to be harmless, and in some cases procedures that should never have been triggered. This guide explains what a PET-CT really shows, who genuinely benefits from one, how to prepare so the images are usable, and how the day itself works.
It also covers the practical question international patients ask most — how a scan is arranged in China, where the equipment, the nuclear medicine case volume and the first total-body PET-CT in the world are all part of the picture. It describes a diagnostic process, not a treatment, and it is not medical advice. Nothing here replaces the judgement of your own physicians.
What a PET-CT actually shows — and what it cannot
A PET-CT combines two technologies in one scanner. The CT component produces an anatomical image: where a structure is, what shape it has, how dense it is. The PET component shows metabolic activity — which cells are taking up a radiolabelled glucose analogue, most often FDG (fluorodeoxyglucose, labelled with the short-lived isotope fluorine-18), faster than their neighbours. The two datasets are fused, so an area of high uptake can be placed precisely on the structure it belongs to.
That is why PET-CT is so useful in cancer. Malignant cells often consume glucose avidly, so they appear as "hot spots" — sometimes before a structural change is large enough to see on CT alone. The same property makes the scan valuable for staging a known cancer, for hunting an unknown primary site, for judging whether treatment is working, and in selected neurological and cardiac cases, where different tracers and protocols apply.
But the mechanism is also the limitation. Infection, tuberculosis, inflammation, healing tissue and some benign tumours consume glucose too, so they light up as well. Beijing's municipal health authority puts it plainly in its own public guidance: the degree of uptake alone cannot distinguish a malignant lesion from a benign one. That judgement also needs the appearances on CT, the clinical picture, and frequently a tissue diagnosis.
The reverse matters just as much. Some cancers do not take up FDG avidly and can be missed — low-grade and well-differentiated tumours, mucinous tumours, certain liver and kidney cancers, and some prostate cancers among them. A negative PET-CT, read together with everything else, is reassuring. It is not proof.
The practical consequence is this: a PET-CT is a piece of evidence, and one of the most powerful pieces available. It is not a verdict.
Who a PET-CT is genuinely for
Where a PET-CT earns its place is in answering a specific clinical question. Current guidance singles out a small number of indications as strongly recommended, and a wider set as appropriate depending on the individual case:
- Strongly recommended — solid pulmonary nodules with a solid component larger than 8 mm, and lymphoma.
- Selectively appropriate — nasopharyngeal, breast, prostate, ovarian and colorectal cancer, melanoma, and bone and soft-tissue tumours, where the treating physician judges that the result will change management.
- Staging and restaging — establishing whether a known cancer is localised or has spread, and re-assessing after treatment, where scar tissue and residual tumour can look identical on CT.
- An unknown primary — a confirmed metastasis whose site of origin has not been found.
- Characterising a lesion — a mass, nodule or lymph node that CT, MRI or ultrasound cannot classify.
- Guiding a biopsy — showing which part of a lesion is metabolically active, so the sample is taken from living tumour rather than from necrotic tissue.
- Selected neurological and cardiac indications — for example pre-surgical evaluation in some forms of epilepsy, or assessment of myocardial viability. These use different tracers and protocols, and are arranged by the relevant specialist.
If you have no symptoms, read this first
This is the part that marketing material tends to leave out, so it is worth stating plainly: a whole-body PET-CT is not a health check, and it is not recommended as a cancer screen for people who have no symptoms and no particular risk factors. International guidelines, including those of the American College of Radiology and the Society of Nuclear Medicine and Molecular Imaging, do not endorse it for that population. Beijing's municipal health authority says the same in its public guidance — a PET-CT is a high-end imaging examination, and it is not advised as a cancer screen for the general public.
The reason is not the cost. It is that a scan of a healthy person will frequently turn up something inconclusive: a nodule, a node, an area of inflammation. Each of those findings can trigger further imaging, blood tests, biopsies and months of worry, and the great majority turn out to be harmless. That is the balance the guidelines are weighing, and it does not favour scanning people who have no clinical question to answer.
The same logic applies after treatment. The American Society of Clinical Oncology advises against using PET or PET-CT for routine surveillance of patients who have completed curative treatment and have no symptoms, unless there is high-level evidence that it changes the outcome for that specific cancer — because false positives lead to unnecessary procedures and further radiation.
If your concern is cancer screening generally, the better answer is a targeted programme chosen for your age, sex, family history and risk profile: the evidence-based screens that exist for specific cancers. You can have a scan of almost any part of your body in China, and our coordinators will help you arrange one. What we would rather do is help you arrange the right one.
Why patients consider having a scan in China
For most people, the reason is access and speed. In a number of health systems a clinically indicated PET-CT means waiting: insurance pre-authorisation can take weeks, and public pathways in some countries are measured in weeks rather than days. In China, as a self-paying patient at a major centre, an appointment is commonly available within days rather than weeks — though this varies by hospital, by city and by tracer availability.
A second reason is equipment and expertise. Major Chinese centres run high-volume nuclear medicine departments on the same scanner platforms you would find in Europe or North America, alongside Chinese-made systems. Interpretation quality in imaging tracks case volume, and the busiest departments see a great deal of complex disease.
A third, and often the real reason, is something specific and hard to get at home: a particular tracer, a particular scanner generation, or a total-body PET service. China is also where the total-body PET-CT was invented and first installed, which is worth understanding before you choose where to have your scan.
One honest caveat. If the same scan is genuinely available to you at home with a short wait and a manageable cost, have it at home — travel adds days and complexity, and your own physicians work with your own records. Coming to China makes most sense when the question is not just "can I get scanned" but "can I get scanned quickly, with the right equipment, as part of a specialist opinion I cannot get locally". Many patients combine a PET-CT with a consultation in the same trip, which is where the journey begins to justify itself.
Not every PET-CT scanner is the same
Two scans with the same name can differ considerably in what they produce. When comparing centres, the things that actually matter are the detector generation (analogue versus digital), whether the scanner uses time-of-flight acquisition, the axial field of view, whether a diagnostic CT with contrast is added to the low-dose CT, and — more than any specification — the experience of the physicians reading the study.
The most significant step change in recent years is the total-body PET-CT. The world's first was developed by United Imaging, based in Shanghai, and installed in April 2019 at Zhongshan Hospital, Fudan University. Its axial field of view is about two metres, against roughly 15 to 20 centimetres on a conventional scanner, and the manufacturer and the hospital report around forty times the sensitivity, a radiation dose of about one fortieth, and whole-body imaging in two to three minutes rather than twenty to thirty.
Those are device specifications rather than claims about outcomes, and they translate into practical advantages in specific situations: a much lower dose matters for children and for patients who need repeated scans to monitor a disease over time, and a very short scan matters for anyone who cannot lie still for half an hour. In 2023 Zhongshan Hospital and United Imaging were joined by fifteen leading hospitals in a multi-centre research platform, and eleven of those hospitals published the first expert consensus on total-body oncological imaging, drawing on more than 23,000 cases.
Two qualifications. Total-body systems are installed at a limited number of centres, so availability is a real constraint rather than something you can assume. And whether any particular scanner is right for your case is a clinical decision made by the physician requesting the study, not a choice to be made from a specification sheet. A modern digital PET-CT read by experienced nuclear medicine physicians is an excellent examination.
Beyond FDG: the tracer decides what can be seen
FDG is the workhorse tracer, and most PET-CT studies use it. It is not the only one, and for some cancers a different tracer shows something FDG cannot.
- FDG — a glucose analogue, used for the large majority of oncological, neurological and cardiac studies.
- PSMA tracers — for prostate cancer, where FDG performs poorly and a prostate-specific tracer is considerably more informative.
- DOTATATE and similar somatostatin analogues — for neuroendocrine tumours, which are frequently FDG-negative.
- FAPI tracers — under active investigation for tumours that are difficult to visualise with FDG, including pancreatic, biliary and some ovarian cancers. Availability remains concentrated in specialist and research centres.
- Amyloid and other brain tracers — used in selected neurological work-ups, rather than in routine oncology.
Preparing for the scan: the part that decides image quality
A PET-CT is unusually sensitive to preparation. The tracer competes with your own blood glucose, and anything that raises glucose or sends it to the wrong tissues degrades the images — which can mean an unreadable study, a repeat scan and another dose. Your hospital will give you instructions; the list below is what they normally cover, so you know what to expect.
- Fast for four to six hours before your appointment. Water is fine, and you should drink it. Do not eat, chew gum, or suck sweets, mints or cough drops — even a small amount of sugar changes the distribution of the tracer.
- Eat differently the day before. A high-protein, low-carbohydrate evening meal keeps blood glucose steadier than a starchy one. Avoid sugary drinks.
- Avoid strenuous activity for about 24 hours beforehand — no gym work, running, heavy lifting, massage, sauna or cupping. Overworked muscle takes up the tracer and can mimic a lesion.
- Stay warm. Cold activates brown fat around the neck and shoulders, which also lights up and can obscure real findings. Bring a sweater, and keep the car warm on the way in.
- Bring a complete medication list, including insulin, oral diabetes medication, steroids and chemotherapy agents — see the next section for why this matters.
- Leave metal at home. No jewellery, and avoid clothing with zips, metal buttons or metallic thread. You may be asked to change into a hospital gown.
- Bring your previous imaging. Earlier CT, MRI or PET-CT studies and their reports, on disc or USB if you have them — comparison across time points is often more informative than any single scan.
- Tell the team if any of these apply: pregnancy or any possibility of it, breastfeeding, inability to lie flat or still, claustrophobia, urinary difficulty, a recent barium contrast study, or a medication you cannot safely stop.
Diabetes and blood sugar: the most common reason a scan is repeated
The tracer behaves like glucose, so it competes with the glucose already in your blood. If your blood glucose is high, your cells are already satisfied, the tumour takes up less tracer, and the scan can be difficult or impossible to read. This is the single most common reason a PET-CT has to be redone.
Centres set their own thresholds, but a commonly used limit is a blood glucose below roughly 11 mmol/L, with the scan working best well below that; several centres ask for tighter control. Non-diabetic patients are usually expected to be under about 7.8 mmol/L. Your blood glucose will be checked on the day, and the scan may be rescheduled if it falls outside the range — not as a formality, but because the images would not be usable.
Medication needs planning, and only on the instruction of your own physician or the nuclear medicine team:
- Metformin increases uptake in the bowel and is commonly paused about 48 hours before the scan. Stopping it affects your diabetes control, so the decision is a clinical one and not something to do unilaterally.
- Insulin timing is adjusted rather than simply stopped. Short-acting insulin is usually timed so the scan falls some hours after the injection; longer-acting preparations may be reduced or, under some protocols, omitted on the day.
- Steroids, certain chemotherapy agents and colony-stimulating factors can all alter tracer distribution. Tell the nuclear medicine team what you take, even if it seems unrelated to the scan.
- Raise your diabetes with the hospital when you book, not on the morning of the scan. A short conversation weeks in advance is what avoids a wasted trip.
Radiation, pregnancy and breastfeeding
A PET-CT involves two sources of radiation: the tracer itself, and the low-dose CT that is used to correct and localise the PET signal. For a whole-body FDG study the effective dose typically falls in the range of roughly 8 to 24 mSv depending on the protocol — a commonly cited figure for a standard study is around 10 to 15 mSv, comparable to a contrast-enhanced CT of the abdomen. Adding a full diagnostic CT with intravenous contrast increases it further, which is one reason the protocol is chosen deliberately rather than by default.
For context, natural background radiation is around 2.4 mSv a year in many places, and the annual limit for people who work with radiation is typically 20 mSv. Below roughly 100 mSv there is no clearly demonstrated increase in cancer incidence across a population. That is the basis for saying a single medically indicated scan is acceptable — it is not a basis for saying the dose is trivial, and it is why the guideline position on scanning people without an indication is as firm as it is.
Three practical consequences follow. Do not repeat an FDG PET-CT within about three months unless there is a specific clinical reason. Avoid the scan in pregnancy, and tell the team if there is any possibility you may be pregnant. If you are breastfeeding, you will normally be asked to interrupt feeding for a period after the scan and to discard milk expressed during that window — protocols vary, so follow the instructions you are given rather than a general rule.
Afterwards, drink plenty of fluids and empty your bladder frequently for the rest of the day to help clear the tracer. For a few hours, avoid prolonged close contact with pregnant women and small children, who are more sensitive to radiation than adults. You will be given a card recording that you received a radioactive tracer — keep it with you, because security and border detectors can register residual activity if you travel within about a day of the scan.
On the day itself — and the report you take away
A PET-CT appointment takes two to three hours from arrival to departure, most of which is waiting rather than scanning. The sequence is fairly consistent between centres.
- Registration and questionnaire — identification, your medication list, allergies, pregnancy status and medical history. Your height and weight are recorded, because the tracer dose is calculated from them.
- Blood glucose check — a finger-prick test before anything is injected. If the reading is outside the acceptable range, the study may be rescheduled.
- Tracer injection — a small intravenous injection, usually in the arm or hand. Nothing about it is painful beyond the needle.
- Uptake period — roughly 40 to 60 minutes resting quietly in a dimly lit room. Do not talk, walk or use your phone, and do not chew. For a brain study you may also be asked not to read or listen to music, because those activities make parts of the brain consume glucose and can blur the image.
- Empty your bladder — immediately before the scan. Tracer collects in urine, and a full bladder can obscure the pelvis.
- The scan — you lie still on a table that moves slowly through the scanner ring. A conventional PET-CT commonly takes 15 to 45 minutes depending on the coverage and the protocol; a total-body system covers the same ground in a few minutes. You are on your own, but watched, and you can speak to the technologist.
- After the scan — you can usually eat and drink normally and leave once the team confirms the study is complete. Keep drinking water and emptying your bladder for the rest of the day.
- The report — standard turnaround at major centres is commonly 24 to 48 hours. Many international departments produce a bilingual report, and some can expedite it for urgent cases. Ask about the timeline when you book rather than assuming it.
Arranging a scan: what we can and cannot do
A PET-CT should not be booked off a website. It is arranged because a physician has a clinical question the scan can answer — which is also the reason the radiation is justified in the first place. In practice the sequence is: your records are reviewed, an appropriate protocol and tracer are selected, and the hospital schedules you.
Public hospitals in China generally do not accept overseas self-referrals for outpatient imaging; you need a hospital record and a request from a physician. This is normally handled through the hospital's international department, or through a coordinator working alongside it.
We do not publish figures for what a scan costs, and we would be cautious about anyone who does: the number depends on the hospital and the city, the generation of the scanner and whether it is a total-body system, whether the study covers the whole body or one region, which tracer is used, whether a contrast-enhanced diagnostic CT is added, and whether translation of the report is included. An estimate that predates a review of your case is a guess. Once your records have been reviewed, the hospital issues a written itemised estimate, and that is the figure to rely on.
What we can do: organise and translate your records, so the hospital can judge whether a scan is appropriate at all; obtain a written clinical opinion; liaise with the hospital's international department and secure the appointment; explain the preparation instructions and check that you have understood them; arrange an interpreter for registration and for the day itself; help with transfers and accommodation; and coordinate follow-up, including sending your images and report to your physician at home.
What we cannot do: we are not a hospital, and we do not perform scans or provide treatment. We do not interpret your images — that is done by the hospital's nuclear medicine physicians, and it is a clinical judgement that belongs with them and with your own doctor. We cannot tell you what your scan means, and we cannot promise what it will find. All information we provide describes institutions, equipment and processes; it never promises an outcome. Any decision to have a scan, and what to do with the result, rests with you and your physicians.
Frequently asked questions
It is used to answer specific clinical questions, above all in cancer: staging a known cancer, establishing whether it has spread, re-assessing after treatment where scar tissue and residual tumour can look identical on CT, searching for the site of origin of a confirmed metastasis, characterising a lesion that other imaging cannot classify, and guiding a biopsy to the metabolically active part of a tumour. It is also used in selected neurological and cardiac cases, with different tracers and protocols. Current guidance strongly recommends it for solid pulmonary nodules over 8 mm with a solid component, and for lymphoma.
No — mainstream guidance advises against it. The American College of Radiology and the Society of Nuclear Medicine and Molecular Imaging do not recommend whole-body PET-CT as a screen for people without symptoms or risk factors, and Beijing's municipal health authority says the same in its public guidance. A scan of a healthy person often produces an inconclusive finding that triggers further tests, biopsies and anxiety, and the great majority of those findings are harmless. A targeted, evidence-based screening programme chosen for your age, sex, family history and risk profile is the better answer.
We do not publish figures, because a quote only means something once your case has been reviewed. What a scan costs depends on the hospital and city, the generation of the scanner and whether it is a total-body system, whether the study covers the whole body or one region, which tracer is used, whether a contrast-enhanced diagnostic CT is added to the low-dose CT, and whether translation of the report is included. Once your records are reviewed, the hospital issues a written itemised estimate, and that is the number to rely on. Be cautious of figures published online without reference to a specific case — they date quickly and often do not come from the hospital.
Yes, but not by self-referral. Public hospitals in China generally do not accept overseas patients booking outpatient imaging directly; you need a hospital record and a request from a physician. In practice the appointment is arranged through the hospital's international department, or through a coordinator working with it. Reports are available in English at many international departments, and a copy of the images on disc or USB is normally provided on request.
Yes. You should avoid food for four to six hours before the appointment; water is fine and you should drink it. Do not chew gum or suck sweets, mints or cough drops, as even a small amount of sugar alters how the tracer distributes. A high-protein, low-carbohydrate meal the evening before helps keep blood glucose steady. Follow the specific instructions your hospital gives you, which may be tighter than this general guidance.
Usually yes, provided your blood glucose is controlled — this is a planning issue rather than a barrier. Many protocols ask for a reading below roughly 11 mmol/L, with tighter control preferred, and your blood glucose is checked on the day before anything is injected. Metformin is commonly paused about 48 hours beforehand because it increases bowel uptake, and insulin timing is adjusted rather than simply stopped. None of that should be done on your own initiative: raise your diabetes with the hospital when you book, so the medication plan is agreed in advance rather than improvised on the morning.
A whole-body FDG PET-CT typically delivers an effective dose in the range of roughly 8 to 24 mSv depending on the protocol, with a commonly cited figure of around 10 to 15 mSv for a standard study — comparable to a contrast-enhanced CT of the abdomen. Adding a full diagnostic CT with contrast increases it. For context, background radiation is around 2.4 mSv a year. A single medically indicated scan is considered acceptable; the reason guidelines discourage scans without an indication is that the dose is not trivial and adds up. Do not repeat an FDG PET-CT within about three months without a specific clinical reason.
Plan on two to three hours at the hospital, most of it waiting rather than scanning. After registration and a blood glucose check, the tracer is injected and you rest quietly for roughly 40 to 60 minutes while it distributes. The scan itself commonly takes 15 to 45 minutes on a conventional scanner, depending on how much of the body is covered; a total-body PET-CT covers the whole body in a few minutes. The written report is normally ready within 24 to 48 hours.
Many international departments at major Chinese hospitals issue bilingual Chinese–English reports, and a copy of the images on disc or USB is normally available on request — ask when you book rather than afterwards. Your physician at home can generally read the DICOM images directly, which is the international standard, and a full set of images plus the written report gives them what they need to reach their own conclusion. We would not rely on machine translation of a clinical report for any decision that affects your treatment.
Both combine a metabolic scan with a structural one, but the structural component differs. PET-CT pairs the PET signal with a CT, which is fast, widely available and gives low-dose attenuation data. PET-MR replaces the CT with an MRI, which delivers no ionising radiation from the structural component and is better at showing soft tissue — the brain, the spine, the liver and the pelvis. It is slower, less widely available and not suitable for everyone. Which is right for you depends on what the physician needs to see, so it is a clinical decision rather than a preference.
Partner hospitals in our network
- Zhongshan Hospital, Fudan University
- Huashan Hospital, Fudan University
- Fudan University Shanghai Cancer Center
- Peking Union Medical College Hospital
Learn more about our Precision medicine programme
Related guides
Sources
- Beijing Admission Standards for Class B Large Medical Equipment Configuration — PET/CT section (2019) — Beijing Municipal Health Commission · checked 2026-11-22
- ACR Appropriateness Criteria — Noninvasive Clinical Staging of Primary Lung Cancer (2019) — American College of Radiology · checked 2026-11-22
- SNMMI Appropriate Use Criteria for 18F-FDG PET/CT for Initial Staging of Malignant Disease (2025) — Society of Nuclear Medicine and Molecular Imaging · checked 2026-11-22
- ASCO Choosing Wisely — 2021 Top Five List in Oncology (Recommendation 8, on PET/CT during routine follow-up) — American Society of Clinical Oncology · checked 2026-11-22